Washington, DC — www.cbinet.com
Position Yourself for Commercial Success in the Evolving Biosimilars Landscape
With new FDA guidelines on the horizon concerning the development of biosimilars, understanding the regulatory and commercial realities of the biologics market is more important than ever. Our summit places unique focus on the assessment of market access, strategies for effective commercialization and options for interchangeability. Join us to explore the current climate for biosimilars business including evaluation of the competitive landscape, reimbursement considerations and patient safety.
This interactive forum covers :